Cardiac Adverse Events Associated with Multiple Myeloma Patients Treated with Proteasome Inhibitors.
- Published in:
- Oncology, 2023, v. 101, n. 5, p. 343, doi. 10.1159/000529341
- By:
- Publication type:
- Article
Works matching IS 00302414 AND DT 2023 AND VI 101 AND IP 5
Results: 6
1
2
Immune Checkpoint Inhibitor-Related Pneumonitis in Lung Cancer Patients with Interstitial Lung Disease: Significance of Radiological Pleuroparenchymal Fibroelastosis.
- Published in:
- Oncology, 2023, v. 101, n. 5, p. 303, doi. 10.1159/000529204
- By:
- Publication type:
- Article
3
Patient-Reported Receipt of Oncology Clinician-Delivered Brief Tobacco Treatment (5As) Six Months following Cancer Diagnosis.
- Published in:
- Oncology, 2023, v. 101, n. 5, p. 328, doi. 10.1159/000528963
- By:
- Publication type:
- Article
4
Malignant Primary and Metastatic Cardiac Tumors: A Single-Center 27-Year Case Review.
- Published in:
- Oncology, 2023, v. 101, n. 5, p. 292, doi. 10.1159/000528915
- By:
- Publication type:
- Article
5
Neoadjuvant Chemotherapy Followed by Cytoreductive Surgery and HIPEC Improves Survival in Peritoneal Metastatic Gastric Cancer.
- Published in:
- Oncology, 2023, v. 101, n. 5, p. 321, doi. 10.1159/000528609
- By:
- Publication type:
- Article
6
Serum Inflammation Parameters and Survival in Hepatocellular Carcinoma Patients: Importance of Albumin and Gamma-Glutamyltranspeptidase.
- Published in:
- Oncology, 2023, v. 101, n. 5, p. 313, doi. 10.1159/000527650
- By:
- Publication type:
- Article